285 related articles for article (PubMed ID: 23449930)
1. Genotoxicity of tobacco smoke-derived aromatic amines and bladder cancer: current state of knowledge and future research directions.
Besaratinia A; Tommasi S
FASEB J; 2013 Jun; 27(6):2090-100. PubMed ID: 23449930
[TBL] [Abstract][Full Text] [Related]
2. Organ specificity of the bladder carcinogen 4-aminobiphenyl in inducing DNA damage and mutation in mice.
Yoon JI; Kim SI; Tommasi S; Besaratinia A
Cancer Prev Res (Phila); 2012 Feb; 5(2):299-308. PubMed ID: 22086680
[TBL] [Abstract][Full Text] [Related]
3. Nonsmoking-related arylamine exposure and bladder cancer risk.
Skipper PL; Tannenbaum SR; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
[TBL] [Abstract][Full Text] [Related]
4. Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens.
Bartsch H; Malaveille C; Friesen M; Kadlubar FF; Vineis P
Eur J Cancer; 1993; 29A(8):1199-207. PubMed ID: 8518034
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological models of carcinogenesis: the example of bladder cancer.
Vineis P
Cancer Epidemiol Biomarkers Prev; 1992; 1(2):149-53. PubMed ID: 1306098
[TBL] [Abstract][Full Text] [Related]
6. Aromatic amines and human urinary bladder cancer: exposure sources and epidemiology.
Talaska G
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2003 May; 21(1):29-43. PubMed ID: 12826031
[TBL] [Abstract][Full Text] [Related]
7. Genotoxicity of environmental tobacco smoke: a review.
Husgafvel-Pursiainen K
Mutat Res; 2004 Nov; 567(2-3):427-45. PubMed ID: 15572289
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
[TBL] [Abstract][Full Text] [Related]
9. Aromatic amines and cancer.
Vineis P; Pirastu R
Cancer Causes Control; 1997 May; 8(3):346-55. PubMed ID: 9498898
[TBL] [Abstract][Full Text] [Related]
10. Tobacco-Specific Carcinogens Induce Hypermethylation, DNA Adducts, and DNA Damage in Bladder Cancer.
Jin F; Thaiparambil J; Donepudi SR; Vantaku V; Piyarathna DWB; Maity S; Krishnapuram R; Putluri V; Gu F; Purwaha P; Bhowmik SK; Ambati CR; von Rundstedt FC; Roghmann F; Berg S; Noldus J; Rajapakshe K; Gödde D; Roth S; Störkel S; Degener S; Michailidis G; Kaipparettu BA; Karanam B; Terris MK; Kavuri SM; Lerner SP; Kheradmand F; Coarfa C; Sreekumar A; Lotan Y; El-Zein R; Putluri N
Cancer Prev Res (Phila); 2017 Oct; 10(10):588-597. PubMed ID: 28851690
[TBL] [Abstract][Full Text] [Related]
11. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County.
Jiang X; Yuan JM; Skipper PL; Tannenbaum SR; Yu MC
Cancer Res; 2007 Aug; 67(15):7540-5. PubMed ID: 17671226
[TBL] [Abstract][Full Text] [Related]
12. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
[TBL] [Abstract][Full Text] [Related]
13. Effects of timing and type of tobacco in cigarette-induced bladder cancer.
Vineis P; Esteve J; Hartge P; Hoover R; Silverman DT; Terracini B
Cancer Res; 1988 Jul; 48(13):3849-52. PubMed ID: 3378220
[TBL] [Abstract][Full Text] [Related]
14. Carcinogen: DNA adducts in tobacco smoke-associated cancer of the upper respiratory tract.
Szyfter K; Banaszewski J; Jałoszyński P; Pabiszczak M; Szyfter W; Szmeja Z
Acta Biochim Pol; 1999; 46(2):275-87. PubMed ID: 10547029
[TBL] [Abstract][Full Text] [Related]
15. Analysis of 4-ABP-DNA adducts and p53 alterations in urinary bladder carcinoma.
Romano G; Garagnani L; Boninsegna A; Ferrari P; Flamini G; De Gaetani C; Sgambato A; Giovanni F; Curigliano G; Ferretti G; Cittadini A; Trentini G
Anticancer Res; 1999; 19(5C):4571-6. PubMed ID: 10650812
[TBL] [Abstract][Full Text] [Related]
16. Detection of carcinogenic aromatic amines in the urine of non-smokers.
Grimmer G; Dettbarn G; Seidel A; Jacob J
Sci Total Environ; 2000 Feb; 247(1):81-90. PubMed ID: 10721145
[TBL] [Abstract][Full Text] [Related]
17. Tobacco smoking and risk of bladder cancer.
Boffetta P
Scand J Urol Nephrol Suppl; 2008 Sep; (218):45-54. PubMed ID: 18815916
[TBL] [Abstract][Full Text] [Related]
18. Hemoglobin-carcinogen adducts as molecular biomarkers in epidemiology.
Tannenbaum SR
Princess Takamatsu Symp; 1990; 21():351-60. PubMed ID: 2134688
[TBL] [Abstract][Full Text] [Related]
19. Haemoglobin adducts of aromatic amines in people exposed to cigarette smoke.
Bryant MS; Vineis P; Skipper PL; Tannenbaum SR
IARC Sci Publ; 1988; (89):133-6. PubMed ID: 3198197
[TBL] [Abstract][Full Text] [Related]
20. DNA adducts of aromatic amines present in tobacco smoke.
Marques MM; Beland FA
IARC Sci Publ; 1994; (125):453-6. PubMed ID: 7806338
[No Abstract] [Full Text] [Related]
[Next] [New Search]
